GABELLI EQUITY TRUST INC 8-K

What Happened

• Gabelli Equity Trust (filed 8‑K on May 7, 2026) announced that Mario J. Gabelli — Trustee, Chairman and Chief Investment Officer of the Fund and a senior executive at GAMCO — experienced a medical incident on March 19, 2026 and was admitted for observation and testing on March 23, 2026. His condition is improving but no return date is provided.
• On March 22, 2026 GAMCO (the parent of the Fund’s adviser, Gabelli Funds, LLC) implemented a longstanding succession plan and named Christopher J. Marangi President of GAMCO. Day‑to‑day operations will be led by co‑CEO Douglas R. Jamieson and Christopher J. Marangi during Mr. Gabelli’s absence. The Fund’s portfolio management is being led by Gabelli Value team Co‑Chief Investment Officers Kevin V. Dreyer and Christopher J. Marangi.

Key Details

• Filing date: Form 8‑K filed May 7, 2026.
• Medical timeline: incident March 19, 2026; hospital observation/testing on March 23, 2026; condition improving, return date unknown.
• Succession action: GAMCO named Christopher J. Marangi President on March 22, 2026; co‑CEO Douglas R. Jamieson and Marangi will lead operations.
• Portfolio management: Kevin V. Dreyer and Christopher J. Marangi are leading the Fund’s portfolio team during Gabelli’s absence.

Why It Matters

• Leadership continuity: The adviser activated a preexisting succession plan to ensure management and investment decisions continue without interruption, which reduces operational risk for shareholders.
• Investment oversight: The Fund’s portfolio management responsibilities are handled by established Co‑CIOs (Dreyer and Marangi), so day‑to‑day investment management is maintained even while Mr. Gabelli is absent.
• No financial changes disclosed: The 8‑K reports personnel and operational updates only; there were no earnings, asset, or policy changes disclosed in this filing.